Skip Navigation
MUSC mobile menu


MUSC set a new high-water mark in FY2018

MUSC sets new record as state's biomedical research leader with more than $276.5 million in funding
flexible stent

New avenue for treating aortic aneurysms

MUSC Health patient becomes first in state to be treated with new flexible stent


Research Highlights

DOD to fund potential treatment for metastatic breast cancer

Hollings Cancer Center researchers hope to find less toxic, more effective treatment.
white brain matter

Study to improve dietary habits and improve brain health

The hormone FGF23 is linked to structural deficits in the brain
mullet fish

Fish from local waters studied for presence of pollutants

Researchers say advisories may be warranted.

Featured Researchers:  MUSC College of Medicine

Dr. Dolloff in laboratory

Dr. Nathan Dolloff wins MUSC FRD's 2018 Innovation Award

Nathan Dolloff, Ph.D. has been highly active in the University’s innovation pipeline with the submission of multiple records of invention, patent filings, small business grants, and out-licensing of MUSC intellectual property. He is Founder of Leukogene Therapeutics Inc., a startup company focused on commercializing new drugs for the treatment of cancer.

Nathan Dolloff, Ph.D.
Assistant Professor of Cell and Molecular Pharmacology, Developmental Cancer Therapeutics

Research Events Calendar

Science Café

MUSC Science Café invites you to learn about science and technology in a fun, comfortable environment.
Date:    October 16, 2018
Time:    5:30 p.m.
             480 King Street
             Charleston, SC 29403

3D Bioprinting Science Cafe
Come learn about state-of-the-art tissue engineering and how it is used to improve patient outcomes!

Join us at the Science Café to hear Dr. Michael Yost talk on tissue engineering and 3D bioprinting and how it holds the promise of customized living implants for patients who have lost tissue due to trauma, disease or genetic disability.

In the News

Genetic Research Related to Autism Spectrum Disorder (WJCT, Sept., 24, 2018)

Leukogene Therapeutics Awarded $2M to Advance Compound for Treatment (Myeloma Reseach News, Sept., 19, 2018)

Noninvasive brain stimulation may soon reach more aphasia patients (Science Daily, Sept 6, 2018)

MUSC to host conference to discuss risks, benefits of cannabis (The Post and Courier, Sept. 6, 2018)


 Contact Us:  Office of the Vice President for Research | 179 Ashley Ave, MSC 001 | Charleston, SC  29425 | 843-792-4333 |


View MUSC's Facebook page Follow MUSC on Twitter View the MUSC Health Youtube channel Read the MUSC Health blog circle arrow MUSC_TAG_SOLID_1C